More than 20% of Meridian's emergency calls are related to falls and lift assists. People need to take more preventative action to stop the increase.

NewAmsterdam Pharma's obicetrapib lowers LDL-C in Phase 3 trials, showing promise as a CETP inhibitor. Read more on NAMS ...